(Q81605921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

J J Rusthoven

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

D C Dale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

M Piccart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

J Glaspy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

A Hamilton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Antimicrobial Agents

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

263-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

More informative abstracts of articles describing clinical practice guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Rules of evidence and clinical recommendations on the use of antithrombotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

1 reference

7 January 2021

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Concurrent RhGM-CSF does not offset myelosuppression from intensive chemotherapy: randomized placebo-controlled study in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hematologic toxicity induced by high-dose chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Transient hypoxaemia during neutrophil recovery in febrile patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2897%2900022-8

7 January 2021

10.1016/S0924-8579(97)00022-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18611813%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference